(Reuters) -Drugmaker Eli Lilly said on Tuesday it is launching an artificial intelligence and machine learning platform that provides biotech companies access to drug discovery models trained on years of Lilly’s research data.

(Reporting by Christy Santhosh in Bengaluru; Editing by Harikrishnan Nair)

See Full Page